- Home
- ASTI vs SBFM Comparison
ASTI vs SBFM Comparison
Compare ASTI & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- SBFM
- Stock Information
- Founded
- ASTI 2005
- SBFM 2006
- Country
- ASTI United States
- SBFM United States
- Employees
- ASTI N/A
- SBFM N/A
- Industry
- ASTI Semiconductors
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- SBFM Health Care
- Exchange
- ASTI Nasdaq
- SBFM Nasdaq
- Market Cap
- ASTI 4.3M
- SBFM 3.7M
- IPO Year
- ASTI N/A
- SBFM N/A
- Fundamental
- Price
- ASTI $2.65
- SBFM $2.90
- Analyst Decision
- ASTI
- SBFM Strong Buy
- Analyst Count
- ASTI 0
- SBFM 1
- Target Price
- ASTI N/A
- SBFM $15.00
- AVG Volume (30 Days)
- ASTI 120.4K
- SBFM 151.9K
- Earning Date
- ASTI 02-19-2025
- SBFM 11-05-2024
- Dividend Yield
- ASTI N/A
- SBFM N/A
- EPS Growth
- ASTI N/A
- SBFM N/A
- EPS
- ASTI N/A
- SBFM N/A
- Revenue
- ASTI $44,673.00
- SBFM $32,959,491.00
- Revenue This Year
- ASTI N/A
- SBFM $59.94
- Revenue Next Year
- ASTI N/A
- SBFM $164.69
- P/E Ratio
- ASTI N/A
- SBFM N/A
- Revenue Growth
- ASTI N/A
- SBFM 61.94
- 52 Week Low
- ASTI $2.25
- SBFM $2.11
- 52 Week High
- ASTI $87.80
- SBFM $572.00
- Technical
- Relative Strength Index (RSI)
- ASTI 47.29
- SBFM 49.22
- Support Level
- ASTI $2.49
- SBFM $2.79
- Resistance Level
- ASTI $2.78
- SBFM $2.94
- Average True Range (ATR)
- ASTI 0.40
- SBFM 0.26
- MACD
- ASTI -0.05
- SBFM -0.03
- Stochastic Oscillator
- ASTI 10.20
- SBFM 16.70
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.